SOUTH SAN FRANCISCO, Calif., Jan. 15, 2016 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA) today announced the appointment of Kelly Bryant as senior director, business development based in CLSA's South San Francisco office. Bryant is responsible for designing and delivering the best in class member experience that CLSA members have come to expect. Bryant will spearhead member development programs and serves as the Bay Area's trusted resource for maximizing CLSA's membership privileges. As the nation's largest statewide life sciences public policy, advocacy and business solutions organization, CLSA serves over 750 life sciences organizations across California.
Bryant will play a key role in business development and forging partnerships throughout the state, while implementing strategic programs that produce premium member value. Additionally, Bryant will serve as an ambassador for CLSA, building industry wide awareness of the CLSA member experience.
"As CLSA continues to grow and support California's life sciences economy and community, we sought an industry veteran to help meet and exceed the member goals and business objectives of our organization," said CLSA President and CEO Sara Radcliffe. "Given Kelly's extensive background and leadership qualities, CLSA members will greatly benefit from this dynamic asset."
Bryant's track record spans from the medical device, technical genomic and health sciences sectors including stints at Ceres, MDVIP (a Proctor & Gamble Co.), and Boston Scientific.
"Kelly embodies exactly what CLSA members expect when they join the most prestigious network of life sciences pioneers, risk takers and thought leaders," said Holly Smithson, Senior Vice President, Business Strategy and Development. "Kelly is a dynamic professional and committed to brokering member successes at all levels. I expect CLSA members may well enjoy her X factor."
Headshot available upon request.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice driving innovation for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
Contact:
Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848
CONTACT: Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



